Pulmonary tumor thrombotic microangiopathy due to lung adenocarcinoma with ROS1 rearrangement successfully treated with Crizotinib under veno-arterial extracorporeal membrane oxygenation.
31 August 2019 (00:00 - 00:00)
Organised by:
About the speaker

Fukui University Hospital, Fukui (Japan)
3 More presentations in this session
Access the full session
The Event
ESC Congress 2019
31 August - 4 September 2019



